AAAAAA

   
Results: 1-12 |
Results: 12
QUALITY-OF-LIFE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN PROLONGED FIRST COMPLETE REMISSION AFTER BONE-MARROW TRANSPLANTATION (ALLOGENEIC OR AUTOLOGOUS) OR CHEMOTHERAPY - A CROSS-SECTIONAL STUDY OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: ZITTOUN R SUCIU S WATSON M SOLBU G MUUS P MANDELLI F STRYCKMANS P PEETERMANS M THALER J RESEGOTTI L DARDENNE M WILLEMZE R
Citation: R. Zittoun et al., QUALITY-OF-LIFE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN PROLONGED FIRST COMPLETE REMISSION AFTER BONE-MARROW TRANSPLANTATION (ALLOGENEIC OR AUTOLOGOUS) OR CHEMOTHERAPY - A CROSS-SECTIONAL STUDY OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 20(4), 1997, pp. 307-315
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP
Authors: ZITTOUN R SUCIU S MANDELLI F DEWITTE T THALER J STRYCKMANS P HAYAT M PEETERMANS M CADIOU M SOLBU G PETTI MC WILLEMZE R
Citation: R. Zittoun et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP, Journal of clinical oncology, 14(7), 1996, pp. 2150-2159
INTENSIVE CHEMOTHERAPY FOR POOR-PROGNOSIS MYELODYSPLASIA (MDS) AND SECONDARY ACUTE MYELOID-LEUKEMIA (SAML) FOLLOWING MDS OF MORE THAN 6 MONTHS DURATION - A PILOT-STUDY BY THE LEUKEMIA COOPERATIVE GROUP OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-IN-CANCER (EORTC-LCG)
Authors: DEWITTE T SUCIU S PEETERMANS M FENAUX P STRIJCKMANS P HAYAT M JAKSIC B SELLESLAG D ZITTOUN R DARDENNE M SOLBU G ZWIERZINA H MUUS P
Citation: T. Dewitte et al., INTENSIVE CHEMOTHERAPY FOR POOR-PROGNOSIS MYELODYSPLASIA (MDS) AND SECONDARY ACUTE MYELOID-LEUKEMIA (SAML) FOLLOWING MDS OF MORE THAN 6 MONTHS DURATION - A PILOT-STUDY BY THE LEUKEMIA COOPERATIVE GROUP OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-IN-CANCER (EORTC-LCG), Leukemia, 9(11), 1995, pp. 1805-1811
PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER
Authors: COMETTA A ZINNER S DEBOCK R CALANDRA T GAYA H KLASTERSKY J LANGENAEKEN J PAESMANS M VISCOLI C GLAUSER MP GIBSON B SANZ M HANN IM FOLLATH F FATIO R FERSTER A VANHOOF A VANLANDUYT H ARENDT V HEMMER R PEETERMANS M PADMOS A SEITANIDES B HATZIYANNI M LOPEZ A PORCELLINI A GREK V CABALLERO D TOGNI P GALLAGHER JG GARAVENTA A MASSIMO L SUGAR A LEGRAND JC OPPENHEIM B PETRIKKOS G BEYTOUT J NIKOSKELAINEN J SHAPIRO M ESTAVOYER JM KERN W
Citation: A. Cometta et al., PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 445-452
COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY
Authors: ZITTOUN R SUCIU S SOLBU G WATSON M MUUS P MANDELLI F STRYCKMANS P PEETERMANS M THALER J WILLEMZE R
Citation: R. Zittoun et al., COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY, Blood, 86(10), 1995, pp. 1718-1718
EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: ZITTOUN R MANDELLI E WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI R VISANI G CARONIA E STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA LP PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML), Leukemia & lymphoma, 13, 1994, pp. 101-101
A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA
Authors: GERHARTZ HH MARCUS R DELMER A ZWIERZINA H SUCIU S DARDENNE M SOLBU G DEWITTE T JACOBS A VISANI G FIERE D SONNEVELD P LABAR B HOFFBRAND AV FENAUX P HAYAT M THYSS A DEBUSSCHER L COIFFIER B SIZOO W WILLEMZE R RIBEIRO M MANDELLI F BURGHOUTS G CAUCHIE C PEETERMANS M ROOZENDAAL KJ GOUDSMIT R DOUER D CASTOLDI GL STERN A ZITTOUN R
Citation: Hh. Gerhartz et al., A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA, Leukemia, 8(1), 1994, pp. 16-23
A COMPARATIVE-STUDY OF LATEX D-DIMER REAGENTS
Authors: VANDERPLANKEN M VERTESSEN F AHARCHI F PEETERMANS M
Citation: M. Vanderplanken et al., A COMPARATIVE-STUDY OF LATEX D-DIMER REAGENTS, Fibrinolysis, 8, 1994, pp. 93-95
ADULT PH-LEUKEMIA IN ALL-3 EORTC STUDY( ACUTE LYMPHOBLASTIC)
Authors: STRYCKMANS P MUUS P MARIE JP FILLET G LABAR B PEETERMANS M KURSTJENS J EFIRA A PAULUS R ROOZENDAAL K SCHAAFSMA R JAKSIC B FEREMANS W VERHEST A BERNIER M DARDENNE M SOLBU G DEWITTE T ZITTOUN R SUCIU S
Citation: P. Stryckmans et al., ADULT PH-LEUKEMIA IN ALL-3 EORTC STUDY( ACUTE LYMPHOBLASTIC), Blood, 84(10), 1994, pp. 10000144-10000144
RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) DURING INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A RANDOMIZED TRIAL FROM EORTC-GIMEMA LEUKEMIA COOPERATIVE GROUPS
Authors: ZITTOUN R MANDELLI F DEWITTE T WILLEMZE R THALER J HAYAT M STRYCKMANS P PEETERMANS M DARDENNE M SOLBU G SUCIU S
Citation: R. Zittoun et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) DURING INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A RANDOMIZED TRIAL FROM EORTC-GIMEMA LEUKEMIA COOPERATIVE GROUPS, Blood, 84(10), 1994, pp. 10000231-10000231
PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL
Authors: ZITTOUN R MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI PR VISANI G CARONIA F STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA G LEONI P PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL, Blood, 82(10), 1993, pp. 10000085-10000085
EVALUATION OF THE ROLE OF THE PRESENCE OF AN HLA-IDENTICAL SIBLING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE PROSPECTIVE RANDOMIZEDSTUDY OF THE LEUKEMIA COOPERATIVE GROUPS OF THE EORTC AND GIMEMA
Authors: DEWITTE T KEATING S MANDELLI F WILLEMZE R STRIJCKMANS P PEETERMANS M HAYAT M LABAR B ZWIERZINA H RESEGOTTI L FERRINI PR CARONIA F VISANI G DARDENNE M SOLBU G PETTI M VEGNA M SUCIU S ZITTOUN R
Citation: T. Dewitte et al., EVALUATION OF THE ROLE OF THE PRESENCE OF AN HLA-IDENTICAL SIBLING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE PROSPECTIVE RANDOMIZEDSTUDY OF THE LEUKEMIA COOPERATIVE GROUPS OF THE EORTC AND GIMEMA, Blood, 82(10), 1993, pp. 10000345-10000345
Risultati: 1-12 |